ENTA News
Archived Headlines
- US IPO calendar heats up with seven deals set to price next week 03/11/13
- US IPO Weekly Recap: Artisan Partners delivers best IPO pop from a US asset manager in years 03/10/13
- Biotech Enanta Pharmaceuticals sets terms for $60 million IPO 03/05/13
- Hit by Sandy, then the market, 3 IPOs fail to price 11/12/12
- Enanta Pharmaceuticals files for a $69 million IPO 11/06/12
US IPO Weekly Recap: Seven deals price, six new filers
style="margin: 0px; font-family: arial, sans-serif; font-size: 13px; line-height: 18px; color: rgb(51, 51, 51); background-color: white;">After a slow start to March in which only three deals priced, the third week of the month saw seven companies debut. Th...read more
Enanta Pharmaceuticals prices IPO at $14, the low end of the range
Enanta Pharmaceuticals, a biotech focused on developing small molecule drugs to use against hepatitis C, raised $56 million by offering 4.0 million shares at $14, the low end of the range of $14 to $16. Enanta Pharmaceuticals plans to list on the NASDAQ under...read more
9 US IPOs planned for the week of Mar 18
The following IPOs are expected to price this week: Aviv REIT (AVIV), a REIT specializing in post-acute and long-term care skilled nursing facilities, plans to raise...read more
US IPO Weekly Recap: Calendar quickly builds, Silver Spring jumps in debut
After several companies set terms last week, the US IPO Calendar is packed for the week of March 18. Nine deals are scheduled to price, which would mark the...read more